Investigator-Initiated Research Grants

Investigator-Initiated Research Grants

Status: ACTIVE
Funder: Mallinckrodt Pharmaceuticals
Last Updated: January 21, 2026

Summary

Mallinckrodt Pharmaceuticals offers Investigator-Initiated Research Grants to enhance the understanding of its marketed and investigational products. This initiative invites physicians and researchers to propose their own studies, assuming full responsibility for study design, regulatory compliance, and result dissemination. The program supports both investigational and marketed products, fostering independent research to improve disease management and therapeutic outcomes. All researchers are encouraged to engage in this collaborative effort, while adhering to strict funding guidelines.

Overview

Background Mallinckrodt Pharmaceuticals is committed to improving the lives of our patients by increasing the medical and scientific understanding of our marketed and investigational products and related therapeutic areas. We can advance the knowledge base on diseases, disease management, and therapeutic outcomes is through support of independent and collaborative research Mallinckrodt is committed to transparency in its interactions with healthcare professionals and health care organizations/institutions consistent with applicable laws and/or codes relating to the pharmaceutical industry. Investigator-Initiated Research (IIR) Investigator Initiated Research (IIR) studies (including, but not limited to clinical trials, registries, health outcomes studies or pre-clinical research studies) involving Mallinckrodt’s drugs and/or devices where a third-party Investigator proposes the study, acts as the Sponsor-Investigator and assumes all responsibility for the conduct of the study. Except in the case of US Government controlled cooperative research group IIR trials, Mallinckrodt may provide drug, device, and/or financial support. These studies can involve investigational or marketed products. This global program is open to all academic and community-based researchers who are interested in conducting their own research. As the sponsor of the study, the investigator and/or institution assume responsibility for all aspects of the study, including: Study design and protocol developmentInstitutional and regulatory approvals and reporting requirementsStudy conduct in accordance with ICH GCP Guidelines and all applicable local and regulatory requirementsDissemination of study results in peer-reviewed publications

Eligibility

You can learn more about this opportunity by visiting the funder's website. This global program is open to all physicians, researchers and institutions who are interested in conducting their own research.

Ineligibility

Funding requests for expenses not associated with the conduct of the study are strictly prohibited.